← All trials
NCT07007195
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 17, 2025
- Primary completion
- Jul 1, 2027
- Completion date
- Jul 1, 2027
- First posted
- Jun 5, 2025
- Last posted
- Sep 9, 2025
- Enrollment
- 132
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of HoustonLead sponsor
- University of HoustonSponsor investigator
- University of OklahomaCollaborator
- University of PittsburghCollaborator
- University of HoustonOfficial
- University of PittsburghOfficial
- Brown UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.